Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shimada

Showing results (71-80 of 295) with videos related to

Pageof 30
Sort By:
Japanese Journal of Clinical Oncology|April 5, 2002
Effect of a 3-hour interval between methotrexate and 5-fluorouracil in the treatment of metastatic colorectal cancerYasuhiro Matsumura, Kunio Haruyama, Tetsuya Hamaguchi, et al.
Anticancer Research|December 11, 2012
Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancerTakako Yanai, Satoru Iwasa, Hirhonobu Hashimoto, et al.
Anticancer Research|October 15, 2013
Weekly paclitaxel as second-line chemotherapy in Japanese patients with advanced gastric cancerMakoto Kadokura, Satoru Iwasa, Yoshitaka Honma, et al.
Annals of Gastroenterological Surgery|February 3, 2021
Indications for pancreaticoduodenectomy affected postoperative outcomes in octogenariansTakehiro Okabayashi, Kenta Sui, Takahiro Murokawa, et al.
Archives of Medical Research|May 17, 2014
Combined assessment of epidermal [corrected] growth factor receptor dual color in situ hybridization and immunohistochemistry with downstream gene mutations in prediction of response to the anti-EGFR therapy for patients with metastatic colorectal cancerNaoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Surgical Technology International|October 3, 2018
A Surgical Case of Inferior Mesenteric Arteriovenous MalformationYusuke Otani, Takehiro Okabayashi, Yuichi Shibuya, et al.
Pharmacology Research & Perspectives|March 16, 2016
Lack of cross-resistance to FF-10501, an inhibitor of inosine-5'-monophosphate dehydrogenase, in azacitidine-resistant cell lines selected from SKM-1 and MOLM-13 leukemia cell linesMotohiko Murase, Hiroyuki Iwamura, Kensuke Komatsu, et al.
Journal of the American College of Surgeons|September 16, 2017
Liver Function Assessment Using Technetium 99m-Galactosyl Single-Photon Emission Computed Tomography/CT Fusion Imaging: A Prospective TrialTakehiro Okabayashi, Yasuo Shima, Sojiro Morita, et al.
Japanese Journal of Clinical Oncology|May 25, 2007
Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatinNarikazu Boku, Atsushi Ohtsu, Shigeaki Yoshida, et al.
Journal of Cancer Research and Clinical Oncology|June 1, 2013
EGFR L2 domain mutation is not correlated with resistance to cetuximab in metastatic colorectal cancer patientsYuriko Ito, Yasuhide Yamada, Kiyoshi Asada, et al.
Pageof 30

Showing results (71-80 of 295) with videos related to

Sort By:
Pageof 30
Japanese Journal of Clinical Oncology|April 5, 2002
Effect of a 3-hour interval between methotrexate and 5-fluorouracil in the treatment of metastatic colorectal cancerYasuhiro Matsumura, Kunio Haruyama, Tetsuya Hamaguchi, et al.
Anticancer Research|December 11, 2012
Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancerTakako Yanai, Satoru Iwasa, Hirhonobu Hashimoto, et al.
Anticancer Research|October 15, 2013
Weekly paclitaxel as second-line chemotherapy in Japanese patients with advanced gastric cancerMakoto Kadokura, Satoru Iwasa, Yoshitaka Honma, et al.
Annals of Gastroenterological Surgery|February 3, 2021
Indications for pancreaticoduodenectomy affected postoperative outcomes in octogenariansTakehiro Okabayashi, Kenta Sui, Takahiro Murokawa, et al.
Archives of Medical Research|May 17, 2014
Combined assessment of epidermal [corrected] growth factor receptor dual color in situ hybridization and immunohistochemistry with downstream gene mutations in prediction of response to the anti-EGFR therapy for patients with metastatic colorectal cancerNaoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Surgical Technology International|October 3, 2018
A Surgical Case of Inferior Mesenteric Arteriovenous MalformationYusuke Otani, Takehiro Okabayashi, Yuichi Shibuya, et al.
Pharmacology Research & Perspectives|March 16, 2016
Lack of cross-resistance to FF-10501, an inhibitor of inosine-5'-monophosphate dehydrogenase, in azacitidine-resistant cell lines selected from SKM-1 and MOLM-13 leukemia cell linesMotohiko Murase, Hiroyuki Iwamura, Kensuke Komatsu, et al.
Journal of the American College of Surgeons|September 16, 2017
Liver Function Assessment Using Technetium 99m-Galactosyl Single-Photon Emission Computed Tomography/CT Fusion Imaging: A Prospective TrialTakehiro Okabayashi, Yasuo Shima, Sojiro Morita, et al.
Japanese Journal of Clinical Oncology|May 25, 2007
Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatinNarikazu Boku, Atsushi Ohtsu, Shigeaki Yoshida, et al.
Journal of Cancer Research and Clinical Oncology|June 1, 2013
EGFR L2 domain mutation is not correlated with resistance to cetuximab in metastatic colorectal cancer patientsYuriko Ito, Yasuhide Yamada, Kiyoshi Asada, et al.
Pageof 30